| abstract |
The invention relates to the treatment of colorectal diseases such as polyps, precancerous stages and prevention and adjuvant treatment of colorectal cancer through the topical administration of immunomodulatory drugs of the imidazoquinoline family such as imiquimod (1- (2-methylpropyl) -1H -imidazo [4,5-c] quinolin-4-amine), resiquimod (4-amino-a, a-dimethyl-2-ethoxymethyl-1H-imidazo [4,5-c] quinolin-1-eta nol), sothyrym (2-methyl-1- (2-methyl-propyl) -1H-imidazo [4,5-c] [1,5] naphthyridine-4-amine). |